Core Viewpoint - China Chengda Engineering Co., Ltd. plans to reduce its stake in Huashu Co., Ltd. by up to 10 million shares, representing 0.28% of the total share capital, within a 90-day period [1] Shareholder Reduction Plan - China Chengda intends to sell no more than 10,000,000 shares, which is capped at 1% of the total shares within any consecutive 90 days [1] - As of the announcement date, China Chengda holds 180,000,000 shares, accounting for 5.01% of Huashu's total share capital [1] Shareholding Structure - The top shareholders include Huai Bei Mining Group with 1,740,036,832 shares (48.41%), Anhui Wantou Industrial Investment Co., Ltd. with 359,473,816 shares (10.00%), and China Chengda Engineering Co., Ltd. with 180,000,000 shares (5.01%) [2] - Huashu Co., Ltd. was listed on the Shanghai Stock Exchange on November 26, 2021, with an initial public offering of 386 million shares at a price of 3.94 yuan per share [2] Fundraising and Financials - Huashu raised a total of 1.521 billion yuan through its initial public offering, with a net amount of 1.402 billion yuan after deducting issuance costs [3] - The company plans to use the raised funds for various projects, including energy efficiency upgrades and production expansions [3] - The total fundraising from two rounds amounts to 1.721 billion yuan [4]

中国经济网北京8月21日讯中触媒(688267.SH)昨日晚间披露《持股5%以上股东减持股份计划公告》。 王婧为中触媒直接持股5%以上股东，无一致行动人。王婧上市以来未减持股份。2025年半年报显示， 王婧为公司第三大股东。 本次减持计划系股东根据自身资金需求进行的减持，不会对公司治理结构及持续经营情况产生重大影 响。减持计划实施不会导致上市公司控制权发生变更。 中触媒于2022年2月16日在上交所科创板上市，发行价格为41.90元/股。中触媒上市发行数量为4405.00 万股，保荐机构(主承销商)为申万宏源证券（000562）承销保荐有限责任公司，保荐代表人为黄霖、刘 国库。目的该股处于破发状态。 中触媒发行募集资金总额为18.46亿元，扣除发行费用后，募集资金净额为16.91亿元。中触媒最终募集 资金净额比原计划多9.07亿元。中触媒于2022年2月11日披露的招股说明书显示，公司拟募集资金7.84亿 元，分别用于"环保新材料及中间体项目""特种分子筛、环保催化剂、汽车尾气净化催化剂产业化项 目"。 中触媒公开发行新股的发行费用合计1.55亿元(不含增值税金额)，其中保荐机构申万宏源证券承销保荐 有限责任 ...

Group 1 - The stock of Frontline Bio (688221.SH) closed at 18.25 yuan, with a decline of 4.4%, currently in a state of breaking issue [1] - Frontline Bio was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 28, 2020, with an issuance of 89.96 million shares, accounting for 25.01% of the total share capital after issuance, at a price of 20.50 yuan per share [1][2] - The total amount raised from the issuance was 184.418 million yuan, with a net amount of 171.729 million yuan, intended for various clinical research projects and working capital [2][4] Group 2 - The highest stock price of Frontline Bio on the listing day was 35.53 yuan, marking the peak since its listing [2] - The underwriting and sponsorship fees for the initial public offering amounted to 12.689 million yuan, with the underwriting and sponsorship fee being 11.613 million yuan [2] - The actual controller of Frontline Bio is Dong Xie, who holds U.S. nationality and has permanent residency in China [3]

Core Viewpoint - Wankai New Materials (301216.SZ) is currently experiencing a decline in stock price, closing at 15.94 yuan with a drop of 3.57%, indicating a state of being below its initial public offering price [1] Group 1: Initial Public Offering and Financials - Wankai New Materials was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on March 29, 2022, with an initial public offering of 85.85 million shares at a price of 35.68 yuan per share [1] - The total funds raised from the IPO amounted to 3.063 billion yuan, with a net amount of 2.915 billion yuan after expenses, exceeding the planned fundraising by 1.411 billion yuan [1] - The company intended to use the raised funds for projects including a 1.2 million ton food-grade PET polymer material project (Phase II), a multifunctional green and environmentally friendly polymer material project, and to supplement working capital [1] Group 2: Subsequent Financial Activities - The total issuance costs for the IPO were 148 million yuan, with underwriting and sponsorship fees accounting for 123 million yuan [2] - On May 31, 2023, Wankai New Materials announced a dividend plan, distributing 3 yuan (pre-tax) for every 10 shares and a bonus issue of 5 shares [2] - The company plans to issue convertible bonds with a total fundraising amount not exceeding 2.7 billion yuan, which will be used for a 1.2 million ton MEG project and to supplement working capital, with the listing date set for September 5, 2024 [2][3]

Core Points - ST Zhongzhuang's stock closed at 3.52 yuan, with a decline of 1.95%, currently in a state of breaking issue [1] - The company was listed on the Shenzhen Stock Exchange on November 29, 2016, with an initial public offering of 75 million shares at a price of 10.23 yuan per share [1] - The total amount raised from the initial public offering was 76.725 million yuan, with a net amount of 67.6032 million yuan, which was 317,700 yuan less than the original plan [1] - The funds raised were intended for various projects including factory production, marketing center construction, R&D center construction, information system construction, and working capital [1] Fundraising Activities - In 2019, ST Zhongzhuang issued convertible bonds with a total face value of 525 million yuan, netting 512.3069 million yuan after deducting issuance costs [2] - The funds from the 2019 bond issuance were deposited into a dedicated account on April 1, 2019, and were verified by Tianzhi International Accounting Firm [2] - In 2021, the company issued convertible bonds with a total face value of 1.16 billion yuan, netting 1.1364 billion yuan after deducting issuance costs [3] - The funds from the 2021 bond issuance were deposited into a dedicated account on April 22, 2021, and were verified by Dahua Accounting Firm [3] - The total amount raised from the three fundraising activities amounts to 2.452 billion yuan [3] Dividend Distribution - On June 7, 2017, ST Zhongzhuang announced a dividend plan of 10 shares for every 10 shares held, with a pre-tax dividend of 2 yuan [3] - The ex-dividend date was set for June 14, 2017, and the record date for shareholding was June 13, 2017 [3]

Core Viewpoint - The specific shareholder, Hangzhou Guangfeng Qiwo Equity Investment Partnership, plans to reduce its holdings in Heshun Technology by up to 655,300 shares, representing 0.8191% of the total share capital, over a three-month period starting from September 4, 2025 [1][2]. Group 1 - The reduction will occur through centralized bidding or block trading, with a limit of 655,300 shares within any continuous 90-day period [1]. - As of the announcement date, Guangfeng Qiwo holds 655,300 shares, making it the fifth largest shareholder of Heshun Technology [2]. - The implementation of this reduction plan will not lead to a change in the company's control or affect its ongoing operations [3]. Group 2 - Heshun Technology was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on March 23, 2022, with an initial public offering of 20 million shares at a price of 56.69 yuan per share [3]. - The company raised a total of 1.134 billion yuan, with a net amount of 1.018 billion yuan after expenses, exceeding the original fundraising plan by 403 million yuan [4]. - The funds raised are intended for the construction of a polyester film production base, a research and development center, and to supplement working capital [4].

Core Points - The company Xi Di Wei (688173.SH) announced a share reduction plan by its Vice President and core technical personnel Fan Jun, who intends to sell up to 3,000,000 shares, representing no more than 0.73% of the total share capital, within three months after the announcement [1] - As of the announcement date, Fan Jun holds 13,049,225 shares, accounting for 3.18% of the total share capital, all of which are unrestricted shares obtained before the company's IPO [1] - The company has no controlling shareholder, with actual controllers being Dai Zuyu, Tao Hai, and Tang Ya [1] Company Background - Xi Di Wei was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 21, 2022, with an initial public offering of 40.01 million shares at a price of 33.57 yuan per share [2] - The stock reached a peak price of 51.88 yuan on its first trading day but is currently in a state of decline [3] - The total funds raised from the IPO amounted to 1.343 billion yuan, with a net amount of 1.221 billion yuan after deducting issuance costs, exceeding the original plan by 640 million yuan [3] Fund Utilization - The funds raised are intended for various projects, including the development and industrialization of high-performance power management chips for consumer electronics and communication devices, as well as new-generation automotive and industrial power management chips [3] - The total issuance costs for the IPO were 122 million yuan, with underwriting and sponsorship fees amounting to 102 million yuan [4]

Group 1 - Tianyue Advanced Technology Co., Ltd. (天岳先进) plans to list its H-shares on the Hong Kong Stock Exchange starting August 19, 2025, with a maximum offering price of HKD 42.80 per share [1] - The company intends to issue a total of 47,745,700 H-shares, with 2,387,300 shares available for public offering in Hong Kong and 45,358,400 shares for international offering [1] - Assuming the offering price of HKD 42.80 per share, the estimated net proceeds from the global offering will be approximately HKD 1,938.1 million, after deducting underwriting commissions and other estimated expenses [1] Group 2 - Tianyue Advanced was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 12, 2022, with an initial offering price of CNY 82.79 per share and a total of 42,971,100 shares issued [2] - The company is currently in a state of share price decline (破发状态) [2] - The total funds raised from the initial public offering amounted to CNY 35.58 billion, with a net amount of CNY 32.03 billion after deducting issuance costs, exceeding the original plan by CNY 1.203 billion [2] Group 3 - The total issuance costs for the initial public offering were CNY 354 million, with underwriting and sponsorship fees amounting to CNY 319 million [3]

Core Viewpoint - Haitian Flavor Industry's H-shares have fallen to a new closing low since its listing, indicating a challenging market reception and investor sentiment [1]. Group 1: Stock Performance - Haitian Flavor Industry's stock closed at HKD 33.36, down 1.71%, marking a new low since its listing [1]. - The stock has dropped 8.1% from its final offering price of HKD 36.30 [3]. Group 2: IPO Details - The total number of H-shares offered globally was 279,031,700, with 55,279,900 shares allocated for the Hong Kong offering and 223,751,800 shares for international offering [1]. - The total proceeds from the IPO amounted to HKD 10,128.9 million, with a net amount of HKD 10,009.6 million after deducting estimated listing expenses [2]. Group 3: Use of Proceeds - Approximately 20% of the net proceeds will be allocated for product development and advanced technology research and process upgrades [3]. - About 30% will be used for capacity expansion, adoption of new technologies, and digital upgrades of the supply chain [3]. - Another 20% is designated for enhancing global brand image, expanding sales channels, and improving overseas supply chain capabilities [3]. - 20% will be used to strengthen the sales network and enhance its penetration capabilities [3]. - The remaining 10% will be allocated for working capital and general corporate purposes [3]. Group 4: Key Investors - Key cornerstone investors include Hillhouse HHLR Advisors, GIC Private Limited, RBC Global Asset Management, and Sequoia China [3].

Group 1 - The stock price of Arctech (688472.SH) fell by 3.56% to 8.93 yuan as of the market close on July 31, 2023, indicating that the stock is currently in a state of decline since its IPO [1] - Arctech was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 9, 2023, with an initial public offering (IPO) price of 11.10 yuan per share. The total number of shares issued before the full exercise of the over-allotment option was 541,058,824 shares, accounting for 15.00% of the total share capital post-issue [1] - After the full exercise of the over-allotment option, the total number of shares issued increased to 622,217,324 shares, representing 16.87% of the total share capital post-issue [1][2] Group 2 - The total amount of funds raised from the IPO was 600,575.29 million yuan before the exercise of the over-allotment option and 690,661.23 million yuan after the full exercise [1][2] - The net amount raised after deducting issuance costs was 572,782.43 million yuan before the over-allotment option and 662,845.46 million yuan after the full exercise [1][2] - The final net amount raised exceeded the original plan by 172,782.43 million yuan before the over-allotment option and 262,845.46 million yuan after the full exercise [2] Group 3 - The total issuance costs for the IPO were 27,792.86 million yuan before the over-allotment option and 27,815.77 million yuan after the full exercise, with underwriting and sponsorship fees amounting to 17,264.15 million yuan [3] - The actual controllers of Arctech are Xiaohua Qu and his spouse Han Bing Zhang, both of whom hold Canadian nationality [4]